Global Anti-inflammatory Biologics Market Research Report 2021

1 Anti-inflammatory Biologics Market Overview
1.1 Product Overview and Scope of Anti-inflammatory Biologics
1.2 Anti-inflammatory Biologics Segment by Type
1.2.1 Global Anti-inflammatory Biologics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Synthetic Type
1.2.3 Biological Type
1.3 Anti-inflammatory Biologics Segment by Application
1.3.1 Anti-inflammatory Biologics Sales Comparison by Application: (2021-2027)
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Global Anti-inflammatory Biologics Market Size Estimates and Forecasts
1.4.1 Global Anti-inflammatory Biologics Revenue 2016-2027
1.4.2 Global Anti-inflammatory Biologics Sales 2016-2027
1.4.3 Anti-inflammatory Biologics Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anti-inflammatory Biologics Market Competition by Manufacturers
2.1 Global Anti-inflammatory Biologics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-inflammatory Biologics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-inflammatory Biologics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-inflammatory Biologics Manufacturing Sites, Area Served, Product Type
2.5 Anti-inflammatory Biologics Market Competitive Situation and Trends
2.5.1 Anti-inflammatory Biologics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-inflammatory Biologics Players Market Share by Revenue
2.5.3 Global Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anti-inflammatory Biologics Retrospective Market Scenario by Region
3.1 Global Anti-inflammatory Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anti-inflammatory Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anti-inflammatory Biologics Market Facts & Figures by Country
3.3.1 North America Anti-inflammatory Biologics Sales by Country
3.3.2 North America Anti-inflammatory Biologics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-inflammatory Biologics Market Facts & Figures by Country
3.4.1 Europe Anti-inflammatory Biologics Sales by Country
3.4.2 Europe Anti-inflammatory Biologics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-inflammatory Biologics Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-inflammatory Biologics Sales by Region
3.5.2 Asia Pacific Anti-inflammatory Biologics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-inflammatory Biologics Market Facts & Figures by Country
3.6.1 Latin America Anti-inflammatory Biologics Sales by Country
3.6.2 Latin America Anti-inflammatory Biologics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-inflammatory Biologics Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-inflammatory Biologics Sales by Country
3.7.2 Middle East and Africa Anti-inflammatory Biologics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-inflammatory Biologics Historic Market Analysis by Type
4.1 Global Anti-inflammatory Biologics Sales Market Share by Type (2016-2021)
4.2 Global Anti-inflammatory Biologics Revenue Market Share by Type (2016-2021)
4.3 Global Anti-inflammatory Biologics Price by Type (2016-2021)

5 Global Anti-inflammatory Biologics Historic Market Analysis by Application
5.1 Global Anti-inflammatory Biologics Sales Market Share by Application (2016-2021)
5.2 Global Anti-inflammatory Biologics Revenue Market Share by Application (2016-2021)
5.3 Global Anti-inflammatory Biologics Price by Application (2016-2021)

6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AbbVie Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Johnson & Johnson Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Amgen Inc
6.3.1 Amgen Inc Corporation Information
6.3.2 Amgen Inc Description and Business Overview
6.3.3 Amgen Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Amgen Inc Product Portfolio
6.3.5 Amgen Inc Recent Developments/Updates
6.4 AstraZeneca PLC
6.4.1 AstraZeneca PLC Corporation Information
6.4.2 AstraZeneca PLC Description and Business Overview
6.4.3 AstraZeneca PLC Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 AstraZeneca PLC Product Portfolio
6.4.5 AstraZeneca PLC Recent Developments/Updates
6.5 Pfizer, Inc
6.5.1 Pfizer, Inc Corporation Information
6.5.2 Pfizer, Inc Description and Business Overview
6.5.3 Pfizer, Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer, Inc Product Portfolio
6.5.5 Pfizer, Inc Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novartis Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Roche Product Portfolio
6.7.5 Roche Recent Developments/Updates
6.8 Sun Pharmaceutical Industries Ltd
6.8.1 Sun Pharmaceutical Industries Ltd Corporation Information
6.8.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
6.8.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sun Pharmaceutical Industries Ltd Product Portfolio
6.8.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Sanofi Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 GlaxoSmithKline Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates

7 Anti-inflammatory Biologics Manufacturing Cost Analysis
7.1 Anti-inflammatory Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-inflammatory Biologics
7.4 Anti-inflammatory Biologics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-inflammatory Biologics Distributors List
8.3 Anti-inflammatory Biologics Customers

9 Anti-inflammatory Biologics Market Dynamics
9.1 Anti-inflammatory Biologics Industry Trends
9.2 Anti-inflammatory Biologics Growth Drivers
9.3 Anti-inflammatory Biologics Market Challenges
9.4 Anti-inflammatory Biologics Market Restraints

10 Global Market Forecast
10.1 Anti-inflammatory Biologics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-inflammatory Biologics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-inflammatory Biologics by Type (2022-2027)
10.2 Anti-inflammatory Biologics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-inflammatory Biologics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-inflammatory Biologics by Application (2022-2027)
10.3 Anti-inflammatory Biologics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-inflammatory Biologics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-inflammatory Biologics by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Anti-inflammatory Biologics Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-inflammatory Biologics Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Anti-inflammatory Biologics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-inflammatory Biologics Covered in This Study
Table 5. Global Anti-inflammatory Biologics Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Anti-inflammatory Biologics Sales Share by Manufacturers (2016-2021)
Table 7. Global Anti-inflammatory Biologics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-inflammatory Biologics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-inflammatory Biologics Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-inflammatory Biologics Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-inflammatory Biologics Product Type
Table 12. Global Anti-inflammatory Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-inflammatory Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Biologics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-inflammatory Biologics Sales by Region (2016-2021) & (K MT)
Table 16. Global Anti-inflammatory Biologics Sales Market Share by Region (2016-2021)
Table 17. Global Anti-inflammatory Biologics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT)
Table 19. North America Anti-inflammatory Biologics Sales Market Share by Country (2016-2021)
Table 20. North America Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT)
Table 23. Europe Anti-inflammatory Biologics Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-inflammatory Biologics Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-inflammatory Biologics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-inflammatory Biologics Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Anti-inflammatory Biologics Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Anti-inflammatory Biologics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-inflammatory Biologics Sales (K MT) by Type (2016-2021)
Table 39. Global Anti-inflammatory Biologics Sales Market Share by Type (2016-2021)
Table 40. Global Anti-inflammatory Biologics Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-inflammatory Biologics Revenue Share by Type (2016-2021)
Table 42. Global Anti-inflammatory Biologics Price (USD/MT) by Type (2016-2021)
Table 43. Global Anti-inflammatory Biologics Sales (K MT) by Application (2016-2021)
Table 44. Global Anti-inflammatory Biologics Sales Market Share by Application (2016-2021)
Table 45. Global Anti-inflammatory Biologics Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-inflammatory Biologics Revenue Share by Application (2016-2021)
Table 47. Global Anti-inflammatory Biologics Price (USD/MT) by Application (2016-2021)
Table 48. AbbVie Corporation Information
Table 49. AbbVie Description and Business Overview
Table 50. AbbVie Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. AbbVie Anti-inflammatory Biologics Product
Table 52. AbbVie Recent Developments/Updates
Table 53. Johnson & Johnson Corporation Information
Table 54. Johnson & Johnson Description and Business Overview
Table 55. Johnson & Johnson Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Johnson & Johnson Anti-inflammatory Biologics Product
Table 57. Johnson & Johnson Recent Developments/Updates
Table 58. Amgen Inc Corporation Information
Table 59. Amgen Inc Description and Business Overview
Table 60. Amgen Inc Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Amgen Inc Anti-inflammatory Biologics Product
Table 62. Amgen Inc Recent Developments/Updates
Table 63. AstraZeneca PLC Corporation Information
Table 64. AstraZeneca PLC Description and Business Overview
Table 65. AstraZeneca PLC Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. AstraZeneca PLC Anti-inflammatory Biologics Product
Table 67. AstraZeneca PLC Recent Developments/Updates
Table 68. Pfizer, Inc Corporation Information
Table 69. Pfizer, Inc Description and Business Overview
Table 70. Pfizer, Inc Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Pfizer, Inc Anti-inflammatory Biologics Product
Table 72. Pfizer, Inc Recent Developments/Updates
Table 73. Novartis Corporation Information
Table 74. Novartis Description and Business Overview
Table 75. Novartis Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Novartis Anti-inflammatory Biologics Product
Table 77. Novartis Recent Developments/Updates
Table 78. Roche Corporation Information
Table 79. Roche Description and Business Overview
Table 80. Roche Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Roche Anti-inflammatory Biologics Product
Table 82. Roche Recent Developments/Updates
Table 83. Sun Pharmaceutical Industries Ltd Corporation Information
Table 84. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 85. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Product
Table 87. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 88. Sanofi Corporation Information
Table 89. Sanofi Description and Business Overview
Table 90. Sanofi Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Sanofi Anti-inflammatory Biologics Product
Table 92. Sanofi Recent Developments/Updates
Table 93. GlaxoSmithKline Corporation Information
Table 94. GlaxoSmithKline Description and Business Overview
Table 95. GlaxoSmithKline Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. GlaxoSmithKline Anti-inflammatory Biologics Product
Table 97. GlaxoSmithKline Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Anti-inflammatory Biologics Distributors List
Table 101. Anti-inflammatory Biologics Customers List
Table 102. Anti-inflammatory Biologics Market Trends
Table 103. Anti-inflammatory Biologics Growth Drivers
Table 104. Anti-inflammatory Biologics Market Restraints
Table 105. Global Anti-inflammatory Biologics Sales Forecast by Type (2022-2027) & (K MT)
Table 106. Global Anti-inflammatory Biologics Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Anti-inflammatory Biologics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Anti-inflammatory Biologics Sales Forecast by Application (2022-2027) & (K MT)
Table 110. Global Anti-inflammatory Biologics Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Anti-inflammatory Biologics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Anti-inflammatory Biologics Sales Forecast by Region (2022-2027) & (K MT)
Table 114. Global Anti-inflammatory Biologics Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Anti-inflammatory Biologics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-inflammatory Biologics
Figure 2. Global Anti-inflammatory Biologics Market Share by Type in 2020 & 2027
Figure 3. Synthetic Type Product Picture
Figure 4. Biological Type Product Picture
Figure 5. Global Anti-inflammatory Biologics Market Share by Application in 2020 & 2027
Figure 6. Arthritis
Figure 7. Respiratory Diseases
Figure 8. Dermatology
Figure 9. Gastroenterology
Figure 10. Others
Figure 11. Global Anti-inflammatory Biologics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Anti-inflammatory Biologics Market Size 2016-2027 (US$ Million)
Figure 13. Global Anti-inflammatory Biologics Sales 2016-2027 (K MT)
Figure 14. Global Anti-inflammatory Biologics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Anti-inflammatory Biologics Sales Share by Manufacturers in 2020
Figure 16. Global Anti-inflammatory Biologics Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Anti-inflammatory Biologics Players: Market Share by Revenue in 2020
Figure 18. Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Anti-inflammatory Biologics Sales Market Share by Region (2016-2021)
Figure 20. Global Anti-inflammatory Biologics Sales Market Share by Region in 2020
Figure 21. Global Anti-inflammatory Biologics Revenue Market Share by Region (2016-2021)
Figure 22. Global Anti-inflammatory Biologics Revenue Market Share by Region in 2020
Figure 23. U.S. Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Anti-inflammatory Biologics by Type (2016-2021)
Figure 48. Sales Market Share of Anti-inflammatory Biologics by Application (2016-2021)
Figure 49. Sales Market Share of Anti-inflammatory Biologics by Application in 2020
Figure 50. Revenue Share of Anti-inflammatory Biologics by Application (2016-2021)
Figure 51. Revenue Share of Anti-inflammatory Biologics by Application in 2020
Figure 52. Manufacturing Cost Structure of Anti-inflammatory Biologics
Figure 53. Manufacturing Process Analysis of Anti-inflammatory Biologics
Figure 54. Anti-inflammatory Biologics Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.